MBRX — Moleculin Biotech Inc · $8.2M cap

Moleculin Biotech Inc (MBRX) is a biotechnology company listed on US.

Latest reported MBRX revenue for 2026-06-30 was $0. Net income was -$20.5M. MBRX currently screens at market cap $8.2M.

Use this MBRX page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the MBRX quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the MBRX SEC filings page. Lician reads the product cache first so this HTML stays unique to Moleculin Biotech Inc even when a live quote feed is slow.

Moleculin Biotech Inc latest statements (FY2025)

Latest cached year on this hub. Full MBRX income, balance, and cash tables.

  • Revenue$0
  • Net Income-$33.6M
  • Total Assets$22.1M
  • Total Debt$0
  • Free Cash Flow-$22.7M

MBRX recent filings